Matching-adjusted indirect comparison (MAIC) of pelabresib (CPI-0610) in combination with ruxolitinib vs. JAK inhibitor monotherapy in patients with intermediate or high-risk myelofibrosis Meeting Abstract
| Authors: | Gupta, V.; Mascarenhas, J.; Kremyanskaya, M.; Rampal, R. K.; Talpaz, M.; Kiladjian, J. J.; Vannucchi, A.; Verstovsek, S.; Colak, G.; Dey, D.; Harrison, C. |
| Abstract Title: | Matching-adjusted indirect comparison (MAIC) of pelabresib (CPI-0610) in combination with ruxolitinib vs. JAK inhibitor monotherapy in patients with intermediate or high-risk myelofibrosis |
| Meeting Title: | 10th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | momelotinib; ruxolitinib; mpn; fedratinib; svr35; tss50 |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 22 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Sep 28-Oct 1 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-10-01 |
| Start Page: | S336 |
| Language: | English |
| ACCESSION: | WOS:000897948100336 |
| PROVIDER: | wos |
| DOI: | 10.1016/s2152-2650(22)01457-4 |
| Notes: | Meeting Abstract: MPN-379 -- Source: Wos |
